daunorubicin has been researched along with n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, M; Liu, X; Lu, Y; Luo, J; Nie, Z; Pan, Y; Wang, T; Wang, Z; Yang, L; Zhan, Y; Zhang, X | 1 |
1 other study(ies) available for daunorubicin and n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide
| Article | Year |
|---|---|
Regulatory role of RBM39 in acute myeloid leukemia: Mediation through the PI3K/AKT pathway.
Topics: Cell Line, Tumor; Daunorubicin; Humans; Leukemia, Myeloid, Acute; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt | 2024 |